1 In December 1988, France authorized L-carnitine as a nutritional fortifier for use in infant formula and general food products
Reported or theoretical concerns may include: Injection-site reactions Transient headache Nausea or mild gastrointestinal discomfort Fatigue or energy fluctuations Unknown long-term effects Potential immune reactions or quality concerns with non-regulated products Theoretical concerns include potential over-suppression of inflammatory responses at high concentrations, so monitoring markers such as CRP and IL-6 during extended use may be recommended by a qualified clinician
References: Della Corte A., Baldassarre M., Sessa F., et al., 2019
Besides checking IGF-1 levels, this insightful blood test will also analyze: Total Testosterone Standard Free Testosterone Standard Estradiol standard Sex Hormone-Binding Globulin (SHBG) Prolactin Prostate-Specific Antigen (PSA) Follicle-stimulating hormone (FSH) Luteinizing hormone (LH) TSH, Free T4, Free T3 Dehydroepiandrosterone Sulfate (DHEA-S) Lipid Panel LDL, HDL, Triglycerides, Total Cholesterol, Ratio HDL/LDL CBC with differential CMP-14 HBa1c Conclusion Like every other drug or medication, IGF-1 should be taken under strict advice from your physician
For longer tapering schedules, separate bottles give you more control
Additional evaluation may involve mass spectrometrybased identity confirmation and stability profiling under defined storage and handling conditions
